An executive who modernizes life-science organizations by connecting operations, technology, quality, and strategy.

Career narrative

I began my career in science, trained to understand complex biological systems and to challenge conclusions that were not supported by evidence. Over time, I found myself drawn to the systems surrounding the science: how work moved through an organization, how quality was built into operations, how teams made decisions, and why strong ideas sometimes failed in execution.

That curiosity moved me across functions and ultimately into executive leadership. I have led from the laboratory, through quality and operations, and into the CEO and CTO roles. Each step broadened my view of what makes a biotechnology company effective.

As CEO of Cell Culture Company, I inherited a business that had been pointed in the wrong direction. The previous strategy centered on pharmaceutical manufacturing that never gained commercial traction. In the first two years, I redirected the company to its core competencies in bioservices and instruments, grew revenue 61%, expanded gross margins by 27 percentage points, and rebuilt the quality infrastructure from the ground up, including ISO 9001:2015 certification in under five months with zero findings. I led the organization through COVID-19 demand surge, post-pandemic normalization, the launch of a third business division, and the full relocation of headquarters and GMP manufacturing operations, on time and under a $1.3M budget.

As CTO, I have built AI and automation tools across the organization, restructured our digital marketing from the ground up, and driven a technology roadmap that connects quality, operations, commercial execution, and board reporting into systems that actually scale.

I am most effective in situations where the problem is cross-functional and resistant to a narrow fix. I look for the underlying constraint, build the system that addresses it, and stay long enough to make sure it holds.